http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110627905-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2019-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110627905-B |
| titleOfInvention | Bifunctional fusion protein targeting VEGF and EGFR and its application |
| abstract | The invention provides a bifunctional fusion protein targeting VEGF and EGFR and its application. The fusion protein provided by the present invention can specifically bind to epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF). The present invention provides a fusion protein targeting and synergistically inhibiting EGFR/VEGF(R) pathway with definite curative effect and high stability. The fusion protein inhibits angiogenesis or cell growth by blocking the phosphorylation of Akt/Stat3 signaling pathway. It has a significant targeted imaging effect and a significant curative effect against PDAC tumors. The fusion protein provided by the invention has a strong target specificity inducing tumor cell apoptosis, and can be used for the treatment of malignant tumors. |
| priorityDate | 2019-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.